철결핍빈혈에 대한 당귀보혈탕의 효과와 안전성: 체계적 문헌 고찰과 메타분석
The Effectiveness and Safety of Danggui Buxue Decoction for Iron Deficiency Anemia: A Systematic Review and Meta-Analysis
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Objectives: This study was aimed at evaluating the effectiveness and safety of Danggui buxue decoction (DBD) for iron deficiency anemia (IDA) by systematic review and meta-analysis of the randomized controlled trials (RCTs). Methods: Randomized controlled trials on the treatment of DBD for IDA patients were selected from among the literature published from the beginning of each database to May 30, 2023 in nine domestic and foreign databases (PubMed, EMBASE, Cochrane, Chinese Academic Journals (CAJ), CiNii Research, J-STAGE, Oriental Medicine Advanced Searching Integrated System (OASIS), Research Information Sharing Service (RISS), and ScienceON). The quality of the literature was evaluated using the Cochrane ROB tool 2.0 (ROB2) and GRADE method. The meta-analysis was conducted using RevMan5.4. Results: A total of 636 patients with IDA were finally selected from the 7 RCTs. The meta-analysis showed that the treatment groups that underwent both DBD and conventional treatment were statistically higher than the control groups that performed only conventional treatment in all indicators that showed effectiveness of DBD such as red blood cell (mean difference (MD) 0.38×1012/L, 95% CI: 0.16-0.60), hemoglobin (MD 12.45 g/L, 95% CI: 10.27-14.63), serum ferritin (MD 3.50 μg/L, 95% CI: 1.71-5.29), and total effective rate (relative risk (RR) 1.13, 95% CI: 1.05-1.21). The incidence of adverse events was 0.39 times lower in the DBD group than in the conventional group (RR 0.39, 95% CI: 0.22-0.70). Conclusion: This study demonstrated the effectiveness and safety of DBD with conventional treatment and further provided a basis for administering DBD to patients with IDA in clinical treatment.
Abstract
Objectives: This study was aimed at evaluating the effectiveness and safety of Danggui buxue decoction (DBD) for iron deficiency anemia (IDA) by systematic review and meta-analysis of the randomized controlled trials (RCTs). Methods: Randomized controlled trials on the treatment of DBD for IDA patients were selected from among the literature published from the beginning of each database to May 30, 2023 in nine domestic and foreign databases (PubMed, EMBASE, Cochrane, Chinese Academic Journals (CAJ), CiNii Research, J-STAGE, Oriental Medicine Advanced Searching Integrated System (OASIS), Research Information Sharing Service (RISS), and ScienceON). The quality of the literature was evaluated using the Cochrane ROB tool 2.0 (ROB2) and GRADE method. The meta-analysis was conducted using RevMan5.4. Results: A total of 636 patients with IDA were finally selected from the 7 RCTs. The meta-analysis showed that the treatment groups that underwent both DBD and conventional treatment were statistically higher than the control groups that performed only conventional treatment in all indicators that showed effectiveness of DBD such as red blood cell (mean difference (MD) 0.38×1012/L, 95% CI: 0.16-0.60), hemoglobin (MD 12.45 g/L, 95% CI: 10.27-14.63), serum ferritin (MD 3.50 μg/L, 95% CI: 1.71-5.29), and total effective rate (relative risk (RR) 1.13, 95% CI: 1.05-1.21). The incidence of adverse events was 0.39 times lower in the DBD group than in the conventional group (RR 0.39, 95% CI: 0.22-0.70). Conclusion: This study demonstrated the effectiveness and safety of DBD with conventional treatment and further provided a basis for administering DBD to patients with IDA in clinical treatment.
참고문헌 (31)
- Kim SY, "Iron Deficiency Anemia : Diagnosis and Treatment", Korean J Med, 92(2), pp.155~161 (2017)
- Yhim HY, "Treatment of Iron-Deficiency Anemia", Korean J Med, 89(1), pp.43~47 (2015)
- The korean society of hematology, "Hematology", pp.60~61 (2018), Panmuneducation
- Lee JO, "Prevalence and risk factors for iron deficiency anemia in the korean population : results of the fifth KoreaNational Health and Nutrition Examination Survey", J Korean Med Sci, 29(2), pp.224~229 (2014)
- "HIRA빅데이터개방포털 질병 소분류(3단 상병) 통계", 건강보험심사평가원[URL]
- 전국한의과대학 간계내과학교수, "肝系內科學", pp.521~531 (2013), 나도
- 彭懷仁, "中醫方劑大辭典", pp.389~392 (1995), 人民衛生出版社
- Kang SA, "Comparison of Dangguibohyel-tang and Erythropoietin on Cyclophosphamide-induced Anemia in Rats", Korean J Oriental Physiology & Pathology, 20(1), pp.31~36 (2006)
- Jin JD, "Effects of Combination of Danggwibohyeol-tang Herbal-acupuncture on Anemic Rats", Korean J Meridian & Acupoint, 20(2), pp.77~92 (2003)
- Zhao MM, "Efficacy and safety of danggui buxue decoction in combination with western medicine treatment of anemia for renal anemia : A systematic review and meta-analysis", Annals of Translational Medicine, 5(6), pp.1~9 (2017)
- Wang L, "Meta-analysis and GRADE evaluation of Danggui Buxue Decoction in the treatment of cancer-related anemia", Journal of Shanxi University of Chinese Medicine, 24(01), pp.1~9 (2023)
- Yu Y, "Danggui Buxue Decoction for Postoperative Anemia : A Meta-analysis", Liaoning Journal of Traditional Chinese Medicine, 46(12), pp.2483~2489 (2019)
- Kim SY, "Health Technology Assessment Methodology : Systematic Review", pp.207~213 (2020), National Evidence based Healthcare Collaborating Agency
- 杜辉, "当归补血汤联合归脾汤对气血两虚证型缺铁性贫血患者的疗效分析", 中医临床研究, 12(30), pp.34~37 (2020)
- 李晓东, "当归补血汤改善气阴不足之维持性血液透析患者功能性缺铁的观察", 大家健康(学术版), 9(08), pp.36~37 (2015)
- 陆泳萍, "加味当归补血汤联合维铁缓释片治疗缺铁性贫血43例临床观察", 中医药导报, 22(02), pp.67~69 (2016)
- 秦春优, "中西医结合治疗小儿缺铁性贫血77例观察", 甘肃中医, (01), pp.29~30 (2007)
- 宋先中, "中西医结合治疗儿童缺铁性贫血140例疗效观察", 现代医药卫生, (03), pp.401~402 (2008)
- 庹小刚, "加味当归补血汤联合维铁缓释片治疗缺铁性贫血的临床观察", 世界最新医学信息文摘, 17(32), pp.93~ (2017)
- 万纳, "当归补血汤联合硫酸亚铁片治疗妊娠合并缺铁性贫血的疗效观察", 内蒙古医学杂志, 53(01), pp.77~78 (2021)
- Kasper DL, "Harrison's principles of internal medicine", pp.996~997 (2017), McGraw-Hill Education Korea
- Lee SI, "Herbal Formula Science", pp.172~ (1990), Young Lim Sa
- 李影迪, "当归多糖与黄芪多糖配伍对骨髓造血干细胞增殖分化的影响", 辽宁中医药大学报, 18(06), pp.31~34 (2016)
- Zheng KY, "Ferulic acid enhances the chemical and biological properties of astragali radix : a stimulator for danggui buxue tang, an ancient Chinese herbal decoction", Planta Med, 80(2-3), pp.159~164 (2014)
- Zhou W, "Potential Mechanism of Danggui Buxue Decoction in Treating Iron Deficiency Anemia Based on Network Pharmacology and Molecular Docking Technology", Medicinal Plant, 12(06), pp.33~36 (2021)
- Huang GC, "Effects of Dang-Gui-Bu-Xue-Tang, an herbal decoction, on iron uptake in iron-deficient anemia", Drug Des Devel Ther, 2(10), pp.949~957 (2016)
- Ai HL, "Effect of Danggui Buxue Decoction on erythrocyte and serum ferritin level in patients with pregnancy anemia", Clinical Journal of Chinese Medicine, 11(36), pp.48~49 (2019)
- The Korean Society of Hematology, "Hematology", pp.65~66 (2011), Panmuneducation
- 도서출판 정담 편집부, "SIM 통합내과학 혈액part 1", pp.49~52 (2013), 도서출판 정담
- Kim MS, "Causes of Hyperferritinemia and Red Blood Cell Transfusion", Korean J Blood Transfus, 29(3), pp.273~281 (2018)